Targeting tumor blood vessels: an adjuvant strategy for radiation therapy (Q34060827)

30 July 2017

1 reference

title

Targeting tumor blood vessels: an adjuvant strategy for radiation therapy (English)

1 reference

adaptive radiation therapy

30 July 2017

main subject

0 references

author

Michael R. Horsman

1 reference

ORCID Public Data File 2021

author name string

Siemann DW

series ordinal

1

1 reference

30 July 2017

Warrington KH

series ordinal

2

1 reference

30 July 2017

Horsman MR

series ordinal

3

1 reference

30 July 2017

publication date

1 October 2000

1 reference

Radiotherapy and Oncology

30 July 2017

published in

1 reference

30 July 2017

volume

57

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

5-12

1 reference

Evidence for mRNA expression of vascular endothelial growth factor by X-ray irradiation in a lung squamous carcinoma cell line

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Pretreatment oxygenation profiles of human soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Carcinoma of the cervix--anaemia, radiotherapy and hyperbaric oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

1 reference

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Tumor angiogenesis and tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Hypoxic Stress Proteins: Survival of the Fittest

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Breast cancer angiogenesis: Therapy target and prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Vinca alkaloids: anti-vascular effects in a murine tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

The Effect of Combining Flavone Acetic Acid and Hyperthermia on the Growth of a C3H Mammary Carcinomain Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Antiangiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Effect of ionizing radiation on AP-1 binding activity and basic fibroblast growth factor gene expression in drug-sensitive human breast carcinoma MCF-7 and multidrug-resistant MCF-7/ADR cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Combined effects of angiostatin and ionizing radiation in antitumour therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Porphyrin photosensitization and phototherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Inhibitors of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Vascular endothelial growth factor and lymph node metastasis in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Antiangiogenesis as a novel therapeutic concept in pediatric oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Current approaches to targeting cancer using antiangiogenesis therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Modification of chemotherapy by nitroimidazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

The prognostic significance of tumor vascularization in patients with localized colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Tumor Hypoxia and Heterogeneity: Challenges and Opportunities for the Future

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Clinical practice of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Clinical trials of antiangiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

Necrosis in non-tumour tissues caused by flavone acetic acid and 5,6-dimethyl xanthenone acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900243-7

7 January 2021

10.1016/S0167-8140(00)00243-7

Identifiers

DOI

1 reference

30 July 2017

1 reference